AJMC® in the Press, January 9, 2026

An article published in Becker’s Payer Issues referenced a study published in the December 2025 issue of The American Journal of Managed Care® (AJMC®). The study, “Mental Health Care Use After Leaving Medicare Advantage for Traditional Medicare,” concluded that switching from Medicare Advantage to Traditional Medicare was associated with increased mental health visits and a shift in provider composition in those who continued using mental health care.

An article from TechTarget referenced a study published in the December 2025 issue of Population Health, Equity & Outcomes, the sister journal of AJMC. The article, “Price Transparency With Gaps: Assessing the Completeness of Payer Transparency in Coverage Data,” found that Aetna and Cigna’s Transparency in Coverage data matched or exceeded their reported provider counts, whereas UnitedHealthcare listed fewer providers.

An article from SingularityHub referenced an article published on AJMC.com, the website of AJMC. The article, “In Vivo CAR T Takes Center Stage, With Results Shared for 4 MRD-Negative Patients,” covered a session held during the American Society of Hematology Annual Meeting & Exposition, in which promising phase 1 trial results were presented regarding in vivo chimeric antigen receptor T-cell therapy for use in cancer treatment.

An article from AJMC entitled, “5 Consequences if ACA Premium Subsidies End in 2026,” was referenced in articles from Shreveport Times and Newsweek. The article from AJMC detailed how the expiration of ACA subsidies would affect premium prices, health care coverage, and hospital and safety-net providers should they not be extended.

An article from TechStock2 referenced the article “FDA Approves Amneal Denosumab Biosimilars, Capping Year of Market Expansion,” published on AJMC’s sister site, The Center for Biosimilars®. The article covered the FDA approval of the denosumab biosimilars, which help to expand options for treating osteoporosis and bone metastases.